Long lasting neutralization of C5 by SKY59, a novel recycling antibody, is a potential therapy for complement-mediated diseases.

MLA

Fukuzawa, Taku, et al. “Long Lasting Neutralization of C5 by SKY59, a Novel Recycling Antibody, Is a Potential Therapy for Complement-Mediated Diseases.” Scientific Reports, vol. 7, no. 1, Apr. 2017, p. 1080. EBSCOhost, https://doi.org/10.1038/s41598-017-01087-7.

APA

Fukuzawa, T., Sampei, Z., Haraya, K., Ruike, Y., Shida-Kawazoe, M., Shimizu, Y., Gan, S. W., Irie, M., Tsuboi, Y., Tai, H., Sakiyama, T., Sakamoto, A., Ishii, S., Maeda, A., Iwayanagi, Y., Shibahara, N., Shibuya, M., Nakamura, G., Nambu, T., … Nezu, J. (2017). Long lasting neutralization of C5 by SKY59, a novel recycling antibody, is a potential therapy for complement-mediated diseases. Scientific Reports, 7(1), 1080. https://doi.org/10.1038/s41598-017-01087-7

Chicago

Fukuzawa, Taku, Zenjiro Sampei, Kenta Haraya, Yoshinao Ruike, Meiri Shida-Kawazoe, Yuichiro Shimizu, Siok Wan Gan, et al. 2017. “Long Lasting Neutralization of C5 by SKY59, a Novel Recycling Antibody, Is a Potential Therapy for Complement-Mediated Diseases.” Scientific Reports 7 (1): 1080. doi:10.1038/s41598-017-01087-7.